BioMarin to Host Third Quarter 2009 Financial Results Conference Call and Webcast on Wednesday, October 28 at 5:... ( NOVATO Calif. Sept. 30 /- BioMarin Ph...)

HOME >> BIOLOGY >> TECHNOLOGY

BioMarin to Host Third Quarter 2009 Financial Results Conference Call and Webcast on Wednesday, October 28 at 5:00 p.m. ET

Date:9/30/2009

NOVATO, Calif., Sept. 30 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, October 28, at 5:00 p.m. ET to discuss third quarter 2009 financial results.

    U.S. / Canada Dial-in Number:  800.299.6183
    International Dial-in Number:  617.801.9713
    Participant Code: 51404008
    Replay Dial-in Number: 888.286.8010
    Replay International Dial-in Number: 617.801.6888
    Replay Code: 51416825

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase I/II clinical development fo
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. BioMarin to Present at the Morgan Stanley Healthcare Conference
2. BioMarin to Present at the Baird Healthcare Conference
3. BioMarin to Present at the Jefferies Healthcare Conference
4. BioMarin to Present at the Goldman Sachs Healthcare Conference
5. BioMarin to Present at the Deutsche Bank Health Care Conference
6. BioMarin to Present at the Baird Growth Stock Conference
7. BioMarin Announces First Quarter 2009 Financial Results
8. BioMarin to Host First Quarter 2009 Financial Results Conference Call and Webcast on Thursday, April 30 at 5:00 p.m. ET (23:00 CET)
9. BioMarin Receives Notice of Allowance for Once Daily Dosing Patent for Kuvan
10. BioMarin to Present at the 4th Annual Citi Biotech Day
11. BioMarins Clinical Trial Application for GALNS for Morquio A Syndrome Accepted by the MHRA

Post Your Comments:

(Date:1/14/2014)... 3D Communications, a leading provider of strategic communications services ... and media events in the United States ... former associate Virginia Cox , JD, is returning to ... Virginia Cox re-joins 3D after more than ... of External Affairs at the U.S. Food and Drug Administration ...

(Date:1/14/2014)... and BETHESDA, Md. ... that they are joining together with two institutes ... help scientists develop more reliable tools for bringing ... faster timeline. Organovo is collaborating with the National ... National Eye Institute (NEI) to develop better and ...

(Date:1/14/2014)... 2014 Global Record Systems, LLC, ... technology solutions for patients, physicians, the biopharmaceutical industry, ... today the signing of a three-year Research Collaboration ... Administration (FDA). This initiative is designed to ... safety, clinical outcomes, and medication adherence. , It ...

(Date:1/14/2014)... Rochester, NY (PRWEB) January 14, 2014 ... to what is now known as “The Doctor’s Plague.” ... they needed to wash their hands. This led, at ... same way, medical interns and hospital staff today don’t ... to their patients. The CBCD explains. , A study ...

Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2 Organovo Announces Collaboration with National Institutes of Health 2 Organovo Announces Collaboration with National Institutes of Health 3 Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2 Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2 Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3

[0] Former FDA Associate Commissioner Returns To 3D Communications [0] Organovo Announces Collaboration with National Institutes of Health [0] Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information [1] Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague”

... to develop blood-based, diagnostic tests ... cancer -,TORONTO, April 29 /PRNewswire-FirstCall/ - ... developing blood-based biomarker tests for the early detection ... that it will undertake a two-year joint project ...

... 16.0 percent to $0.58 from $0.50 in first-quarter ... intangible assets from the 2003 spin-off, increased 14.5 ... Total net revenues increased 14.4 percent to a ... percent to a record $2.3 billion- Generic dispensing ...

... ST. LOUIS, Missouri, April 29 , ... Specialty Content , Elsevier, ... information products and services, announced today that ten ... ( http://www.mdconsult.com ),its online clinical reference tool. This ...

GeneNews to conduct joint project funded by MYR 5 million grant from Malaysian government Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010 Elsevier Launches Ten New eBook Specialty Collections on MD Consult

(Date:3/13/2014)... morning, I let the cat out and started the ... must distinguish not just what happened and where, but ... and after. New research from the University of California, ... the brain called the hippocampus stores memories by their ... after. , "We need to remember not just what ...

(Date:3/13/2014)... have been clarified by numerous investigations, fitness enthusiasts ... of cardio- and resistance training influence the effectiveness ... has now been the focus of a series ... Physical Activity at the University of Jyvskyl. The ... and coordinated by PhD student Moritz Schumann has ...

(Date:3/12/2014)... the nation will soon blast into orbit for research ... Station (ISS). , The citizen science project, known ... who are investigating how microbes from different places on ... on the International Space Station. , Six of the ... and the Bay Area, including the 50-yard line of ...

Breaking Biology News(10 mins):What happened when? How the brain stores memories by time 2 Performing cardio- and resistance training during the same session: Does the order matter? 2 Microbes in space 2 Microbes in space 3

[0] What happened when? How the brain stores memories by time [0] Performing cardio- and resistance training during the same session: Does the order matter?[0] Microbes in space

... their native language of 1 and 0 absolutes but struggle ... While scientists are making slow, incremental progress in their quest ... body language, a more straightforward method of communication may help ... of researchers led by Charlie Kemp, director of the Center ...

... researchers from across North America have been awarded ... Stanford University,s Woods Institute for the Environment, the ... is funded by the David and Lucile Packard ... 20 mid-career academic environmental scientists as fellows, who ...

... within a large field you discover a plant that has ... take your special plant to the laboratory where you find ... of a single gene. This is a great observation; however, ... the world, well adapted to the particular region they grow ...

Cached Biology News:Robot fetches objects with just a point and a click 2 Robot fetches objects with just a point and a click 3 Robot fetches objects with just a point and a click 4 19 researchers selected as 2008 Leopold Leadership Fellows 2 19 researchers selected as 2008 Leopold Leadership Fellows 3 19 researchers selected as 2008 Leopold Leadership Fellows 4 Less can be more, for plant breeders too 2 Less can be more, for plant breeders too 3

Robot fetches objects with just a point and a click 19 researchers selected as 2008 Leopold Leadership Fellows Less can be more, for plant breeders too

... handy dispensers save space and organize ... other garb. They are the perfect ... used in labs, processing and manufacturing. ... and the particles they attract. Open-slot ...

... dispensers save space and organize gloves, ... garb. They are the perfect benchtop ... in labs, processing and manufacturing. Clear ... the particles they attract. Many other ...

... microRNA expression profiling and built on ... on-chip synthesis platform. These microarrays are ... microRNA Expression Profiling Service. ... Microarray contains all known mammal microRNAs ...

... Proteolytic degradation is critical to ... short-lived and regulatory proteins as important ... cellular metabolism, heat shock and stress ... surface receptors and ion channels, cell ...

Biology Products:

Safety Glasses Dispensers from Terra Universal, Inc.Apparel Dispenser from Terra Universal, Inc.Mammals microRNA Microarray from LC Sciences IRS Extract from GeneTex